GROVE HOUSE SURGERY — All Prescriptions & Medications
Practice Code: H82043 | BOGNOR REGIS, PO21 4JB
Over the last 12 months, GROVE HOUSE SURGERY prescribed 243,859 items across 677 different medications at a total cost of £2,545,879 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diltiazem hydrochloride | 10 | 450 | £531 | +115.9% ▲ |
| Aclidinium bromide | 10 | 10 | £309 | -62.3% ▼ |
| Midazolam hydrochloride | 10 | 37 | £835 | -30.6% ▼ |
| Riluzole | 10 | 560 | £2.9K | -3.6% ▼ |
| Tube feed 1 kcal/ml peptide based (0914032) | 10 | 64.0K | £1.5K | +12.1% ▲ |
| Brimonidine tart (Rosacea) | 10 | 300 | £320 | +93.7% ▲ |
| 10 | 901 | £173 | +48.5% ▲ | |
| 10 | 127 | £716 | +66.4% ▲ | |
| 10 | 10 | £143 | +16.4% ▲ | |
| 10 | 33 | £1.2K | +9.8% ▲ | |
| 10 | 100 | £142 | +52.6% ▲ | |
| 10 | 600 | £1.9K | -21.7% ▼ | |
| 10 | 340 | £1.7K | -21.0% ▼ | |
| 10 | 320 | £2.0K | -21.7% ▼ | |
| Prucalopride | 11 | 616 | £330 | -71.7% ▼ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 11 | 616 | £301 | -32.7% ▼ |
| Moxonidine | 11 | 308 | £50 | -80.2% ▼ |
| Indacaterol/glycopyrronium | 11 | 330 | £340 | -75.6% ▼ |
| Imipramine hydrochloride | 11 | 2,128 | £72 | -56.9% ▼ |
| Doxycycline monohydrate | 11 | 452 | £258 | +1.3% vs avg |
| Rifaximin | 11 | 616 | £2.9K | -59.0% ▼ |
| Mebendazole | 11 | 114 | £10 | -3.9% ▼ |
| Ivermectin | 11 | 58 | £750 | +12.7% ▲ |
| Propylthiouracil | 11 | 1,288 | £127 | -12.5% ▼ |
| Norethisterone | 11 | 552 | £89 | -77.3% ▼ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 11 | 150.0K | £4.0K | -4.0% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 11 | 11 | £139 | +1.3% vs avg |
| Ipratropium bromide | 11 | 11 | £75 | -32.2% ▼ |
| Clindamycin phosphate | 11 | 600 | £115 | -33.1% ▼ |
| Erythromycin | 11 | 360 | £132 | -19.0% ▼ |
| Benzalkonium chloride | 11 | 3,750 | £84 | -4.1% ▼ |
| 11 | 18 | £763 | +26.3% ▲ | |
| 11 | 12 | £880 | -69.2% ▼ | |
| 11 | 500 | £124 | -25.2% ▼ | |
| 11 | 840 | £211 | -43.1% ▼ | |
| 11 | 120 | £346 | +74.4% ▲ | |
| 11 | 330 | £175 | -50.7% ▼ | |
| 11 | 350 | £2.4K | +115.3% ▲ | |
| Linaclotide | 12 | 672 | £857 | -34.3% ▼ |
| Enoxaparin | 12 | 132 | £525 | -41.5% ▼ |
| Prasugrel | 12 | 644 | £236 | -61.8% ▼ |
| Alprostadil | 12 | 40 | £497 | -29.8% ▼ |
| Goserelin acetate | 12 | 12 | £2.8K | -72.8% ▼ |
| Degarelix | 12 | 12 | £1.4K | -30.9% ▼ |
| Tube feed 1 kcal/ml with fibre (0914011) | 12 | 71.0K | £1.1K | +16.3% ▲ |
| Azelastine hydrochloride | 12 | 152 | £116 | +1.0% vs avg |
| Azelastine hydrochloride | 12 | 264 | £120 | +7.1% ▲ |
| Budesonide | 12 | 19 | £181 | -22.8% ▼ |
| 12 | 25 | £389 | -25.0% ▼ | |
| 12 | 23 | £711 | +17.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.